Evidence map›Paper›PMID 41244285›Full record

ArticleASM case reports2025

Genomic analysis of a

Björn Herrmann, Andreas Sälléber, Rene Kaden

Abstract readCase Reports
In one paragraph

Article in ASM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. False-positiveJournal of clinical microbiology · 2026
    Article
  2. Global distribution of Xpert CT/NG assayEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Björn HerrmannSection of Clinical Microbioloby, Department Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0001-8729-2306
Andreas SälléberDepartment of Clinical Microbiology, Hospital of Västmanland, Västerås, Sweden.
Rene KadenSection of Clinical Microbioloby, Department Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-2111-9751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diagnostics of sexually transmitted infections, such as Case Summary: Analysis of pharyngeal samples from two men who have sex with men was positive for NG in the Abbott Alinity m STI assay, but negative upon confirmation testing with the Cepheid Xpert CT/NG assay. A pharyngeal culture isolate was obtained from one of the two men. The isolate tested negative for being NG in four different commercial nucleic acid amplification tests. A laboratory-developed PCR based on two targets gave inconclusive results, with positive detection for the Conclusion: Confirmatory tests with alternative targets are essential for accurate analysis of NG, especially in low-prevalence settings. Evaluation of diagnostic tools to ensure accurate detection of NG is also needed.

Indexed as

Abbott Alinity m STIdiagnosticsNeisseria gonorrhoeaeNeisseria meningitidisPCR

Identifiers

PMID41244285
PMCPMC12584176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.